PMA device
Consulta CRT-D, Maximo II CRT-D, Protecta XT CRT-D and Protecta CRT-D
Medtronic Cardiac Rhythm Disease Management · Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D) (NIK, Class III) · First FDA decision Mar 17, 2008, newest Mar 5, 2019Heart failureVentricular arrhythmia and sudden cardiac arrest
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
0
Naming "Consulta CRT-D Maximo"
MAUDE reports
0
Brand "Consulta CRT-D Maximo", since 2015
PubMed studies
0
Mentioning "Consulta CRT-D Maximo"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Consulta CRT-D, Maximo II CRT-D, Protecta XT CRT-D and Protecta CRT-D
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 4 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Implantable Cardioverter DefibrillatorsNational analysisReview closedCAG-00157R4Updated Nov 19, 2026
- Implantable Cardioverter Defibrillators (ICDs)National determinationOn the books20.4Updated Sep 28, 2026
- Implantable Cardioverter Defibrillators (ICDs)National analysisReview closedCAG-00157NUpdated Sep 15, 2026
- Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web BasedLocal determinationIn effectL34087CGS Administrators, LLCUpdated Aug 28, 2026
- Implantable DefibrillatorsNational analysisReview closedCAG-00157R2Updated Nov 19, 2026
- Wireless Stimulation Endocardially for Cardiac Resynchronization Therapy System (WiSE CRT)National analysisReview closedCAG-00471NUpdated Nov 18, 2026
- Implantable Defibrillators - Clinical TrialsNational analysisReview closedCAG-00157RUpdated Sep 15, 2026
- Implantable DefibrillatorsNational analysisReview closedCAG-00157R3Updated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Consulta CRT-D Maximo", any status and sponsor, newest update first.
No registered device study names "Consulta CRT-D Maximo".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Consulta CRT-D Maximo", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NIK
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Consulta CRT-D Maximo"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NIK.
- Amplia MRI CRT-DMedtronic Cardiac Rhythm Disease Management · PMA 2022
- Promote/+/RF/QAbbott Medical · PMA 2026
- Contak CDBoston Scientific Corp · PMA 2022
- Frontier/Frontier Ii/Anthem Family of Crt-PsAbbott Medical · PMA 2016
- Microny Family of PacemakersAbbott Medical · PMA 2016
- Sensolog/Dialog/Regency Family of PacemakersSt. Jude Medical, Inc. · PMA 2016
- Contak Cd,easytrakBoston Scientific Corp · PMA 2026
- Quadra Assura/Unify Assura Family of Crt-DsAbbott Medical · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.